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Abstract 
Background: Prolonged, severe, unalleviated fatigue may be disabling whether it occurs on its own or in 
conjunction with medical or psychiatric conditions. This paper compares the prevalence and correlates of 
prolonged fatigue in general population samples in Ukraine versus the US. Methods: Population surveys 
were conducted in 2002 in both Ukraine (Ukraine World Mental Health [WMH] Survey) and the US 
(National Comorbidity Survey-Replication; NCS-R). Both surveys administered the Composite International 
Diagnostic Interview (CIDI 3.0), which contained modules assessing: neurasthenia (prolonged fatigue); 
mood, anxiety, and alcohol/drug use disorders; chronic medical conditions; and demographic 
characteristics. Multivariable logistic regression was used to examine risk factors in each country. 
Results:The lifetime prevalence of prolonged fatigue was higher in Ukraine (5.2%) than the US (3.7%). In 
both countries, one-fifth of individuals with prolonged fatigue had no medical or DSM-IV psychiatric 
condition. Also in both settings, fatigue was significantly associated with socio-demographic 
characteristics (being female, not working, and married before) as well as early onset and adult episodes 
of mood/anxiety disorder. Fatigue prevalence in Ukraine increased with age, but decreased in the US at 
age 70. Unique risk factors for fatigue in Ukraine included lower socio-economic status, Ukrainian versus 
Russian ethnicity, and cardiovascular disease. Unique risk factors in the US were parental depression/
anxiety, adult episodes of alcohol/drugs, pain conditions, and other health problems. Conclusions: The 
lifetime prevalence of prolonged fatigue in Ukraine was 40% higher than that found in US data. In addition, 
fatigue prevalence increased sharply with age in Ukraine perhaps due to limited social and medical 
resources and greater comorbidity. 
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Background: Prolonged, severe, unalleviated fatigue may be disabling whether it occurs on its 
own or in conjunction with medical or psychiatric conditions. This paper compares the 
prevalence and correlates of prolonged fatigue in general population samples in Ukraine versus 
the U.S.  
Methods:  Population surveys were conducted in 2002 in both Ukraine (Ukraine World Mental 
Health [WMH] Survey) and the U.S. (National Comorbidity Survey-Replication; NCS-R).   Both 
surveys administered the Composite International Diagnostic Interview (CIDI 3.0), which 
contained modules assessing: neurasthenia (prolonged fatigue); mood, anxiety, and alcohol/drug 
use disorders; chronic medical conditions; and demographic characteristics. Multivariable 
logistic regression was used to examine risk factors in each country.  
Results: The lifetime prevalence of prolonged fatigue was higher in Ukraine (5.2%) than the 
U.S. (3.7%). In both countries, one-fifth of individuals with prolonged fatigue had no medical or 
DSM-IV psychiatric condition. Also in both settings, fatigue was significantly associated with 
sociodemographic characteristics (being female, not working, and married before) as well as 
early onset and adult episodes of mood/anxiety disorder. Fatigue prevalence in Ukraine increased 
with age, but decreased in the U.S. at age 70. Unique risk factors for fatigue in Ukraine included 
lower socio-economic status, Ukrainian vs Russian ethnicity, and cardiovascular disease. Unique 
risk factors in the U.S. were parental depression/anxiety, adult episodes of alcohol/drugs, pain 
conditions, and other health problems.  
Conclusions: The lifetime prevalence of prolonged fatigue in Ukraine was 40% higher than that 
found in U.S. data.  In addition, fatigue prevalence increased sharply with age in Ukraine 
perhaps due to limited social and medical resources and greater comorbidity.  
 











Prolonged, debilitating fatigue without clear etiology is embodied in two similar conditions, 
neurasthenia and chronic fatigue syndrome (CFS).  Both conditions feature disabling medically 
unexplained fatigue that is associated with the unusual symptom of post-exertional fatigue (or 
exhaustion). Neurasthenia appears in the ICD-10 [1] and is characterized by at least 3 months of 
persistent and distressing feelings of exhaustion after minor mental or physical effort. Also 
required is one additional symptom (muscular aches, sleep disturbance or irritability) and an 
inability to recover from exhaustion through rest or relaxation.  By comparison, CFS [2] requires 
6 months of unremitting fatigue and 4 out of 8 secondary symptoms of which the most frequently 
reported are cognitive difficulties, sleep disturbance, and post-exertional malaise [3].  An early 
report by Farmer et al. [4] found that 97% of CFS subjects also met ICD-10 criteria for 
neurasthenia (without exclusion criteria). 
     With regard to prevalence, the most recent U.S. population-based study of neurasthenia [5] 
estimated lifetime prevalence at 4.9%.  CFS lifetime prevalence is considerably lower with a 
generally accepted U.S. estimate of about .5% [6, 7].  Both CFS and neurasthenia have been 
prospectively linked to prior stressful life events [8-11].  More generally, debilitating prolonged 
fatigue is a common feature in a wide variety of conditions, such as chronic inflammatory, 
infectious, neurological, and psychiatric diseases as well as cancer [12]. 
     Prolonged fatigue has also been studied in aging populations and may be an early indicator of 
the onset of medical conditions. Two large sample investigations in the elderly (ages 65-85) [13, 
14] found a high prevalence (18-24%) of self-reported persistent fatigue or lack of energy that 
was linked to physical and role impairments. Furthermore, subjective reports of tiredness after 
activities in the elderly have been found in several studies [reviewed in 15] to be a strong 
independent predictor of functional decline, disability, and death.  
Aims 
     The purpose of this study was to compare the prevalence of prolonged fatigue in Ukraine and 
the U.S. using data obtained from the neurasthenia module of Composite International 
Diagnostic Instrument (CIDI). More specifically, this paper examined the lifetime prevalence of 
neurasthenia in these two countries, and their age-of-onset distributions, patterns of comorbidity, 
and sociodemographic correlates. A secondary question concerned the relationships of comorbid 
conditions to fatigue in the elderly. Throughout the text, the term “prolonged fatigue” will be 




     The Ukraine World Mental Health Survey (WMH; 16) and the National Comorbidity Survey-
Replication (NCS-R; 17) have been described previously. Briefly, the Ukraine WMH 
implemented a four-tiered stratified cluster design to obtain a nationally representative sample of 
4,725 adults aged 18 and older (response rate 78.3%). The sample was administered the paper-
pencil version of the CIDI 3.0, which contains two parts in order to reduce respondent burden. 
All 4,725 respondents received Part I, which assessed mood and anxiety disorders and 
alcoholism. Part I respondents who met criteria for one or more disorders and a random sample 
(16%) of the remaining respondents were administered Part II (N = 1,720). The analysis of 
prolonged fatigue used the Part II sample. Weighting procedures allow the generalization of 
findings to the population of adults in Ukraine (see Data analysis). 
U.S. Sample 
    The NCS-R was a national probability sample assessed with the computerized version of the 
CIDI 3.0 in 2002-2003 (data available from www.icpsr.org).  The NCS-R used a multi-stage 
cluster sampling design. A total of 9,282 respondents aged 18 and older participated in Part 1 of 
the NCS-R (response rate = 73.0%). The Part II sample (N=5962) was the focus of our analysis 
of prolonged fatigue.  Weighting procedures allow the generalization of findings to the 
population of adults in the United States (see Data Analysis). 
Instrument 
     The CIDI 3.0 is a widely administered and reliable structured diagnostic tool designed for use 
by lay interviewers. More detail on the CIDI can be obtained elsewhere [18] including 
translation details used for the Ukraine CIDI [16].  
Prolonged fatigue 
     Using the Neurasthenia Module of the CIDI, prolonged fatigue was operationalized as 
follows: (a) several months or more of weakness, tiredness or exhaustion while performing 
minor everyday physical or mental tasks, (b) the tiredness or weakness was not alleviated by 
resting or relaxing, (c) during the months or years when the problems were most severe, the 
respondent got tired most or nearly every day,  and (d) the tiredness had “a lot” or “extreme” 
impact on work, social life and/or personal relationships. Lifetime prevalence rates were derived 
from participants who fulfilled these criteria.  
     In comparison to previous studies [e.g., 19], our inclusion criteria specified symptom severity 
in addition to presence or absence of each symptom. Information on severity and frequency of 
symptoms may yield more accurate prevalence estimates because symptoms are assessed in a 
precisely defined and reproducible manner [3]. To ensure that the prevalence of prolonged 
fatigue was not driven largely by individuals reporting a cancer diagnosis, which is strongly 
linked to fatigue [e.g., 20], we also created a version of the prolonged fatigue diagnosis that 
eliminated individuals who reported ever being diagnosed with cancer. There were no other 
medical or psychiatric exclusion criteria.  
Risk factors 
     Demographic characteristics, childhood onset (early childhood) factors, and adult episodes of 
psychiatric and medical conditions (adult risk factors) were included in the analysis. We 
considered seven demographic variables, five of which were identical in the two samples: sex, 
age (18-49, 50-69, 70+), employment status (currently working or not currently working), 
education (high school or less, beyond high school) and marital status (married before but not 
currently, currently married, or never married). Ethnicity and socio-economic status were 
constructed differently for the two samples: (1) Ethnicity in the U.S. was dichotomized into 
white vs non-white; ethnicity in Ukraine was based on whether the interview was conducted in 
Ukrainian versus Russian; (2) socioeconomic status was assessed in the U.S. by household 
income of  >$65,000 versus <$65,000 and in Ukraine by a rating of family financial status  as 
adequate (enough money for durables), inadequate (not enough money for clothing) and very 
inadequate (not enough money for food). 
     Four early childhood factors were analyzed using identical variables for the U.S. and Ukraine, 
namely, (1) early onset (aged 19 or earlier) of DSM-IV alcohol or drug abuse (substance use 
disorder), and of mood or anxiety disorders (depression, dysthymia, (2) generalized anxiety 
disorder, panic disorder, social phobia and agoraphobia, (3) parental anxiety or mood disorder 
(depressive episodes lasting 2+ weeks that interfered with life activities or episodes of 
nervousness or anxiety lasting 1+ month or anxiety/panic attacks), and (4) parental alcoholism 
(alcohol problems that interfered with life activities during a significant portion of the 
respondent’s childhood). The WMH-CIDI contained special probes designed to maximize recall 
of age of onset.  
     Five adult risk factors were measured identically in the two samples: (1) adult episodes (age 
20+) of DSM-IV drug or alcohol abuse (substance use disorder); (2) mood or anxiety disorder 
(disorders are identical to list in previous paragraph); (3) cardiovascular health problems (stroke 
or heart attack within the last 12 months or lifetime diagnosis of heart disease or high blood 
pressure); (4) pain conditions (arthritis or rheumatism, chronic back or neck problems, 
frequent/severe headaches or any other chronic pain condition over the past 12 months); and (5) 
other major health conditions (asthma, tuberculosis, other chronic lung disease, diabetes, ulcer, 
thyroid disease, neurological disorders, epilepsy, kidney disease, and liver disease).   
Data analysis 
     To approximate the population distributions for both Ukraine and the U. S. on key socio-
demographic variables and to account for differential probability of selection and non-response 
bias into part II, the sample was weighted [16,34,35]. Statistical analyses were conducted using 
R statistical software [21] to adjust for the stratified sampling design and sample weights.  Odds 
ratios and 95% confidence intervals were obtained from binary logistic regression analyses. 
Multivariable analyses were conducted in three steps in order to model the temporal progression 
of potential risk of prolonged fatigue: (1) Step 1 included the significant (p<0.05) demographic 
risk factors; Step 2 added the significant childhood risk factors while retaining significant risk 
factors from Step 1; and (3) Step 3 added the adult risk factors while retaining significant risk 
factors from Steps 1 and 2.  
Results 
Demographic characteristics 
     Table 1 shows the demographic characteristics of the Ukraine and the U.S. samples. Both 
samples were relatively evenly split between male and female respondents, while the Ukraine 
sample had more years of education but with greater unemployment. Parental, childhood and 
adult mental and physical health risk factors tended to be similar between the two samples, 
though some modest differences are noted in the table. 
Prevalence of Prolonged Fatigue 
     The lifetime prevalence of neurasthenia, i.e., prolonged fatigue was 5.2% (SE=0.7%; 
89/1720) in Ukraine and 3.7% (SE=0.2%; 213/5692) in the U.S. (p<.05). Information on age of 
onset and recency of prolonged fatigue was available for 59.8% (n=53) of fatigue cases in 
Ukraine and 91.9% (n=196) of cases in the U.S. In Ukraine, the median age of onset was 34.16 
(range 10 - 73; IQR 20.4 – 44.87). A total of 2.8% SE=0.3%; 48/1720) of cases reported 
prolonged fatigue in the year prior to interview.  Among U.S. cases with prolonged fatigue, the 
median age of onset was 32.6 (range 6 - 81; IQR 22 - 41). A total of 1.9% (SE=0.2%; 108/5692) 
of cases reported prolonged fatigue in the year prior to interview. Lifetime prevalence decreased 
only minimally to 5.0% (SE=0.7%; 85/1720) in Ukraine and 3.4% (SE=0.2%; 194/5692) when 
excluding individuals with a lifetime diagnosis of cancer. The diagnostic criteria without physical 
or mental health exclusions are used throughout the remainder of the manuscript.  
 Only about one in ten individuals with prolonged fatigue in Ukraine (9.0%) and the U.S. 
(11.2%) had no other lifetime physical conditions. Less than one in four individuals with 
prolonged fatigue in the U.S. (23.2%) and less than half in Ukraine (39.7%) had no lifetime 
psychiatric disorders. We note, however, that these conditions were not necessarily comorbid in 
that they did not always occur simultaneously within the same individual. 
Bivariate Risk Factors Associations 
     In both the U. S. and Ukraine, demographic risk factors were significantly associated with 
risk of prolonged fatigue (Table 2). In both countries females, individuals not working, 
individuals married before (divorced or widowed) and those with lower socio-economic status 
were at increased risk of prolonged fatigue. Race and education were not significant factors in 
the U.S., but were significant in Ukraine (higher rates of prolonged fatigue in the less educated 
and in Ukrainian speakers). Importantly, while age was significantly related (p<.001) to fatigue 
in both samples, the pattern of significance was quite different. In Ukraine, fatigue risk increased 
linearly across age categories, whereas in the U.S. cohort, there was a sharp decrease in risk in 
the age 70+ cohort (Figure 1).  
     In the United States, all four childhood risk factors, including both parental variables, were 
strongly related to lifetime risk of prolonged fatigue with odds ratios ranging from 1.7 (Early 
onset Alcohol/Drug) to 3.8 (Early Onset Mood/Anxiety). In Ukraine, only one of the four risk 
factors was significant (Mood/Anxiety; OR=2.7 (1.8, 4.0).  As with childhood risk factors, all 
five adult risk factors showed significant associations with lifetime prolonged fatigue risk in the 
U. S. In Ukraine, three of the five adult risk factors were associated with prolonged fatigue risk: 
mood/anxiety disorder, cardiovascular health problems and pain conditions (Table 2). 
Multivariable analysis 
     In the multivariable analysis, four demographic variables remained significantly associated 
with lifetime risk of lifetime prolonged fatigue after adjusting for the other significant 
demographic variables in each sample. Two of the four demographic variables (female and age) 
were significant in both samples (Female: U.S., p<.001, UK: p<0.01; Age: U.S., p<.001, UK: p 
<.05), while marital status (p<.01) and employment status (p<.001) were significant in the U.S., 
whereas language (p<.05) and income (p<.001) were significant in Ukraine.  
     After controlling for other childhood and demographic risk factors, only 2 of the 4 risk factors 
remained significant for lifetime prolonged fatigue in the U.S. sample: Early Onset 
Mood/Anxiety (p<.001) and Parental Anxiety/Depression (p<0.001).  Early Onset Mood/Anxiety 
was the only significant childhood risk factor in the Ukraine sample (p<.001).  
     Finally, only adult mood/anxiety disorders was a significant risk factor for prolonged fatigue 
in multivariable models for both the U.S. (p<.001) and Ukraine (p<.01). Cardiovascular diseases 
was a significant predictor (p<.001) in Ukraine, while adult substance use disorder, pain and 
other chronic health conditions were significant predictors (p<.01) in the U.S. Based on 
significant risk factors in the multivariable models, Figures 2a and 2b show the cumulative risk 
for prolonged fatigue as the total number of risk factors increases in both the U.S. (ten possible 
risk factors) and Ukraine (seven possible risk factors) samples. 
 
Discussion 
     This paper presented findings on the epidemiology of lifetime prolonged fatigue, using a 
neurasthenia assessment in the Ukraine (Ukraine-World Mental Health Survey [Ukraine-WMH]) 
and in the U.S. (2003 National Comorbidity Survey-Replication [NCS-R]). The lifetime 
prevalence of neurasthenia (i.e., prolonged fatigue) was found to be 5.2% in Ukraine, about 40% 
higher than that found in the U.S. data (3.7%). The female: male ratio for prolonged fatigue 
prevalence was about 2:1 in both populations. The 12 month interference with activities such as 
housework and ability to work were similar between Ukraine and the U.S., but interference with 
close relationships and social life was actually greater (p<0.01 and p<0.01, respectively) in the 
U.S.  We also found that a higher number of risk factors (e.g., adult mood and anxiety) was 
predictive of a higher percentage of individuals reporting fatigue symptoms that fulfilled criteria 
for neurasthenia. In addition, prolonged fatigue prevalence spiked in the age 70 and over group 
in Ukraine, while U.S. rates declined for the elderly.  
     Increased risk of prolonged fatigue was linked to females, individuals not working, 
individuals married before (divorced or widowed) and those with lower socio-economic status. 
In the U.S., whites had higher rates of prolonged fatigue than non-whites. The risk factors for 
prolonged fatigue were largely similar between the U.S. and Ukraine, but with higher risk for 
individuals with alcohol abuse history in the U.S. sample and for those with lower education in 
Ukraine.  
     In a recent U.S. population study [5], the adjusted prevalence rate for lifetime neurasthenia 
without exclusionary criteria was 4.9%.  Our lifetime estimates of 3.7-5.2% without exclusionary 
criteria are in a comparable range.  Our use of symptom severity criteria may have increased the 
ability to screen those individuals with clinically significant symptoms.  
The Impact of Life Events  
 
     Stressful life events have been prospectively linked to both CFS and neurasthenia [8-11].   In 
Ukraine, psychological risk factors for prolonged fatigue may in part be a long-range 
consequence of a number of potentially traumatic events that have occurred in that region. These 
events include the social and economic dislocations following the dissolution of the Soviet 
Union in the 1990s, and a large number of industrial, mining, and transport accidents [16], most 
notably the Chernobyl nuclear plant accident in 1987.   
     In related work, new pilot data based on a discrete catastrophic life event (9/11 responders to 
the World Trade Center attacks in the U.S.) suggest that the prevalence of prolonged fatigue is 
unusually high in this group [22]. Paths from major life events to prolonged fatigue (via 
mediation or moderation) may include sleep disturbance, poor social support, ongoing stress, 
depression, anxiety [23], and/or medical comorbidities [12]. However, it is not clear how these 
intervening variables may exert their putative effects on fatigue severity and incidence. For 
instance, stress may directly lead to fatigue or be mediated by sleep disturbance. Furthermore, it 
is unclear whether factors such as social support might be able to alter the strength of the life 
events–fatigue relationship (i.e., as a moderator).  
Psychiatric and medical morbidities 
     Childhood and adult psychiatric risk factors including mood/anxiety disorder and alcohol 
abuse were identified for prolonged fatigue. Because the symptom of fatigue occurs in mood and 
anxiety disorders, it has been proposed that prolonged fatigue states such as neurasthenia and 
CFS may be somatic variants of psychiatric disorders [24].  However, fatigue appears to be 
qualitatively different in prolonged fatigue states because it is worsened by physical and mental 
effort, including exercise [25]. By comparison, exercise is a moderately effective treatment for 
depression and anxiety [26].   Furthermore, although fatigue may be a feature of anxiety and 
depressive disorders, prolonged fatigue can occur in the absence of psychiatric disorder [6, 23].    
         The high prevalence of chronic medical comorbidities in both the Ukraine and U.S. 
samples suggest additional influences on prolonged fatigue states. For instance, fatigue is a 
frequent complaint in cardiovascular disease [27], with exertion fatigue particularly prominent in 
heart failure [28].  In addition, fatigue may constitute the first clinical manifestation of heart 
disease [27].  Similarly, fatigue in the less distinct conditions of neurasthenia and CFS may 
capture important elements, including pre-clinical manifestations, of other diseases especially in 
older populations [29]. 
Prolonged fatigue and the elderly 
     Figure 1 shows the sharply higher percentage of individuals with prolonged fatigue in the age 
70 and over group in Ukraine (11.1%) as compared to a much lower rate in the U.S. elderly 
subgroup (1.9%).  One partial explanation for this higher fatigue prevalence in Ukraine is that 
fewer public and private resources are available for health and other services to the elderly. Even 
for those elderly with “relative-responsible” families who are providing care, there are often 
feelings of profound social and psychological isolation [30].  Less social support has also been 
linked to neurasthenia [23].  
     Furthermore, the post- Soviet decline in health and the increase in chronic medical illness 
such as heart disease, diabetes, and cancer [30, 31] may disproportionately impact the elderly.  
As such, prolonged fatigue may reflect advancing heart disease as well as undiagnosed 
preclinical conditions, physical declines with age, and sedentary activity levels [15].  
Limitations 
     The size of the U.S. sample was nearly twice as large as the Ukraine cohort which increased 
the ability to identify significant risk factors and may account for some of the differences 
between the two groups.  However odds ratio estimates suggest that sample size may not be the 
only explanation. Findings in the over 50 group may reflect survivor bias [32], a significant 
concern in regions with life expectancy <70, as found in the Ukraine. In addition, memory for 
fatigue symptoms and episodes over the lifespan is subject to recall bias that may inflate the 
severity of remembered symptoms [33].   
Conclusion 
     Prolonged fatigue as diagnosed with neurasthenia criteria shows considerably higher 
prevalence in the Ukraine in comparison to the U.S. Fatigue was associated with both medical 
and psychiatric comorbidities, with only a small minority reporting “pure” fatigue without 
comorbid conditions. Fatigue prevalence was sharply higher in the elderly in Ukraine in 
comparison to the U.S.  
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